MedTrace Logo

Effects of VSL#3 on Neuro-cognitive Profile of HIV Patients

NCT02276326 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-02-08

No results posted yet for this study

Summary

Aim of the study is to evaluate the effects of a change in the intestinal microflora on the neuro-cognitive profile of patients with HIV infection receiving HAART treatment. Improvements will be evaluated with questionnaires on Quality of life and Cognitive and Behavior function.

20 patients will be enrolled and will receive 4 sachets of VSL#3 per day.

Conditions

  • HIV Seropositivity
  • ART

Interventions

DIETARY_SUPPLEMENT

VSL#3 sachets

4 sachets a day for 4 months

Sponsors & Collaborators

  • Azienda Policlinico Umberto I

    lead OTHER

Principal Investigators

  • Gabriella D'Ettorre · Policlinico Umberto I Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02276326 on ClinicalTrials.gov